MSACL 2018 US Abstract Title: Protein Biomarker Immunoaffinity Mass Spectrometry:
Enabling Translational Pharmacology of Biologics in Pharma Hendrik Neubert Pfizer Inc
Description
Y/N
Source
Grants
no
Salary
yes
Pfizer
Board Member
no
Stock
yes
Pfizer
Expenses
no
IP Royalty: no
Planning to mention or discuss specific products or technology of the company(ies) listed above: